SCHEMBL6837211

SCHEMBL6837211

COc1ccc(Cn2cc3c(n2)COCc2sc(N)nc2-3)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 8/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MAPT P10636 1/20 0.42
MPI P34949 1/20 0.42
DRD2 P14416 1/20 0.39
KCNH2 Q12809 1/20 0.39
AADAT Q8N5Z0 1/20 0.38
LMNA P02545 2/20 0.36
GAA P10253 1/20 0.36
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
LTA4H P09960 1/20 0.34
HPGD P15428 1/20 0.34
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
MYC P01106 1/20 0.33
WDR5 P61964 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6837318 0.87 ALDH1A1 (0.47) ADORA1ALDH1A1KDM4EMAPTMPI
SCHEMBL15260941 0.83 AADAT (0.42) ADORA1ALDH1A1KDM4EMAPTMPI
SCHEMBL6837465 0.81 AADAT (0.39) ADORA1ALDH1A1KDM4EMAPTMPI
SCHEMBL369019 0.81 DRD2 (0.37) ADORA1ALDH1A1KDM4EMAPTMPI
SCHEMBL368608 0.81 ADORA1 (0.40) ADORA1ALDH1A1KDM4EMAPTMPI
SCHEMBL371092 0.80 ADORA1 (0.39) ADORA1ALDH1A1KDM4EMAPTMPI
SCHEMBL6837141 0.79 ACHE (0.35) ALDH1A1MAPTKCNH2AADATLMNA
SCHEMBL367046 0.79 KDM4E (0.46) ADORA1ALDH1A1KDM4EMAPTMPI
SCHEMBL369640 0.78 KDM4E (0.49) ADORA1ALDH1A1KDM4EMAPTMPI
SCHEMBL15303772 0.77 ALDH1A1 (0.42) ADORA1ALDH1A1KDM4EMAPTMPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130210807-A1 Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors. MERCK SHARP & DOHME CORP. 2013-08-15 US disclosed
WO-2012006760-A1 TRICYCLIC COMPOUNDS AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2012-01-19 WO disclosed
WO-2012008999-A2 TRICYCLIC COMPOUNDS AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210807-A1 Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors. GRM3, GRM6, GRM1 ADORA1 253/4885ALDH1A1 3550/4885KDM4E 1020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.